Skip to main content

#151228

Anti-HLADQ1 [TAL 4.1]

Cat. #151228

Anti-HLADQ1 [TAL 4.1]

Cat. #: 151228

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Human Leukocyte Antigen DQ1 (includes DQ5 and 6 )

Class: Monoclonal

Application: ELISA ; FACS ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-HLADQ1 [TAL 4.1]
  • Research fields: Immunology
  • Clone: TAL 4.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 28 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS ; IHC ; WB
  • Description: TAL 4.1 can be used for tissue typing and detection of class II products.
  • Immunogen: Whole cells from the B line WT46
  • Isotype: IgG2b
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Human Leukocyte Antigen DQ1 (includes DQ5 and 6 )
  • Molecular weight: 28 kDa
  • Target background: Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D).

Applications

  • Application: ELISA ; FACS ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Kanangat et al. 2018. Hum Immunol. 79(7):558-563. PMID: 29656111.
  • Bodmer et al. 1984. Br Med Bull. 40(3):267-75. PMID: 6205714.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.